市場調査レポート

商品コード

1233635

膣用抗真菌薬の世界市場：市場シェアの約3分の1はクロトリマゾール系薬剤が占める

Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs

出版日: 2023年01月30日 | 発行: Persistence Market Research

| ページ情報: 英文 250 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 769,986円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピーはできません。PDFの印刷もできません。

PDF (Multi User License)

USD 7,600 1,194,264円

レポートPDFを同一企業内の5名様までご利用頂けるライセンスです。PDF内のテキストの編集が可能です。PDFの印刷は5部までとし、そのご利用はPDFのご利用範囲に準拠します。

PDF (Corporate User License)

USD 10,600 1,665,684円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキストの編集が可能です。印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界の膣用抗真菌薬市場について調査分析し、市場概要、動向、機会、セグメント別・地域別の市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

イントロダクション/主要な調査結果
過去の市場分析：薬剤別
現在・将来の市場分析と予測：薬剤別
- フルコナゾール
- ナイスタチン
- フルシトシン
- クロトリマゾール
- ケトコナゾール
- テルビナフィン
- その他
市場の魅力分析：薬剤別

第9章世界の膣用抗真菌薬市場分析と予測：投与経路別

イントロダクション/主要な調査結果
過去の市場分析：投与経路別
現在・将来の市場分析と予測：投与経路別
- 経口
- 局所
市場の魅力分析：投与経路別

第10章世界の膣用抗真菌薬市場分析と予測：流通チャネル別

イントロダクション/主要な調査結果
過去の市場分析：流通チャネル別
現在・将来の市場分析と予測：流通チャネル別
- 院内薬局
- 小売薬局
- オンライン薬局
市場の魅力分析：流通チャネル別

第11章世界の膣用抗真菌薬市場分析と予測：地域別

イントロダクション/主要な調査結果
過去の市場分析：地域別
現在・将来の市場分析と予測：地域別
- 北米
- ラテンアメリカ
- 欧州
- 東アジア
- 南アジア
- オセアニア
- 中東・アフリカ
市場の魅力分析：地域別

第12章北米の膣用抗真菌薬市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在・将来の市場分析と予測：市場分類別
- 国別
- 薬剤別
- 投与経路別
- 流通チャネル別
市場の魅力分析
- 国別
- 薬剤別
- 投与経路別
- 流通チャネル別
市場動向
主要な市場参入企業：強度マッピング
促進要因と抑制要因：影響分析
国レベルの分析と予測
- 米国
- カナダ

第13章ラテンアメリカの膣用抗真菌薬市場分析と予測

第14章欧州の膣用抗真菌薬市場分析と予測

第15章東アジアの膣用抗真菌薬市場分析と予測

第16章南アジアの膣用抗真菌薬市場分析と予測

第17章オセアニアの膣用抗真菌薬市場分析と予測

第18章中東・アフリカ（MEA）の膣用抗真菌薬市場分析と予測

第19章市場構造分析

市場分析：企業層別
市場集中度
主要企業の市場シェア分析
市場プレゼンス分析

第20章競合分析

競合ダッシュボード
競合ベンチマーク
競合の詳細
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited
- Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Dr. Reddy's Laboratories
- SCYNEXIS, Inc.
- Basilea Pharmaceutica Ltd.
- Astellas Pharma Inc.
- Grupo Ferrer Internacional, S.A.
- Pacgen Life Science Corporation
- NovaDigm Therapeutics, Inc.
- Cidara Therapeutics, Inc.
- Amplyx Pharmaceuticals Inc.

第21章前提条件と使用されている頭字語

第22章調査手法

図表

List of Tables

Table 01: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 02: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
Table 03: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 04: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Region
Table 05: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 06: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 07: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
Table 08: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 09: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 10: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 11: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
Table 12: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 13: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 14: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 15: Europe Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
Table 16: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 17: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 18: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 19: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
Table 20: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 21: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 22: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 23: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
Table 24: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 25: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 26: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 27: Oceania Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
Table 28: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
Table 29: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
Table 30: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
Table 31: Middle East & Africa Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
Table 32: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel

List of Figures

Figure 01: Global Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 02: Global Vaginal Antifungals Market Forecast & Y-o-Y Growth, 2022-2032
Figure 03: Global Vaginal Antifungals Market Absolute $ Opportunity (US$ Mn) Analysis, 2021-2032
Figure 04: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Drug
Figure 05: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug
Figure 06: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Drug
Figure 07: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Route of Administration
Figure 08: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Route of Administration
Figure 09: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Route of Administration
Figure 10: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
Figure 11: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel
Figure 12: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Distribution Channel
Figure 13: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 14: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
Figure 15: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Region
Figure 16: North America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 17: North America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 18: North America Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 19: North America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 20: North America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 21: North America Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 22: North America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 23: North America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 24: North America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 25: North America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 26: U.S. Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 27: Global Vs. U.S. Growth Comparison
Figure 28: U.S. Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 29: U.S. Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 30: U.S. Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 31: Canada Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 32: Global Vs. Canada. Growth Comparison
Figure 33: Canada Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 34: Canada Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 35: Canada Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 36: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 37: Latin America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 38: Latin America Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 39: Latin America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 40: Latin America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 41: Latin America Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 42: Latin America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 43: Latin America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 44: Latin America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 45: Latin America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 46: Mexico Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 47: Global Vs Mexico Growth Comparison
Figure 48: Mexico Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 49: Mexico Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 50: Mexico Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 51: Brazil Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 52: Global Vs. Brazil. Growth Comparison
Figure 53: Brazil Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 54: Brazil Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 55: Brazil Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 56: Argentina Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Growth Comparison
Figure 58: Argentina Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 59: Argentina Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 60: Argentina Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 61: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 62: Europe Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 63: Europe Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 64: Europe Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 65: Europe Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 66: Europe Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 67: Europe Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 68: Europe Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 69: Europe Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 70: Europe Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 71: UK Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 72: Global Vs. UK Growth Comparison
Figure 73: UK Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 74: UK Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 75: UK Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 76: Germany Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 77: Global Vs. Germany Growth Comparison
Figure 78: Germany Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 79: Germany Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 80: Germany Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 81: Italy Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 82: Global Vs. Italy Growth Comparison
Figure 83: Italy Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 84: Italy Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 85: Italy Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 86: France Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 87: Global Vs France Growth Comparison
Figure 88: France Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 89: France Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 90: France Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 91: Spain Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Growth Comparison
Figure 93: Spain Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 94: Spain Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 95: Spain Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 96: Russia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 97: Global Vs Russia Growth Comparison
Figure 98: Russia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 99: Russia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 100: Russia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 101: BENELUX Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 102: Global Vs BENELUX Growth Comparison
Figure 103: BENELUX Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 104: BENELUX Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 105: BENELUX Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 106: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 107: East Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 108: East Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 109: East Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 110: East Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 111: East Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 112: East Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 113: East Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 114: East Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 115: East Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 116: China Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 117: Global Vs. China Growth Comparison
Figure 118: China Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 119: China Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 120: China Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 121: Japan Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Japan Growth Comparison
Figure 123: Japan Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 124: Japan Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 125: Japan Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 126: South Korea Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 127: Global Vs South Korea Growth Comparison
Figure 128: South Korea Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 129: South Korea Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 130: South Korea Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 131: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 132: South Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 133: South Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 134: South Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 135: South Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 136: South Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 137: South Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 138: South Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 139: South Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 140: South Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 141: India Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 142: Global Vs. India Growth Comparison
Figure 143: India Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 144: India Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 145: India Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 146: Indonesia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 147: Global Vs. Indonesia Growth Comparison
Figure 148: Indonesia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 149: Indonesia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 150: Indonesia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 151: Malaysia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 152: Global Vs. Malaysia Growth Comparison
Figure 153: Malaysia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 154: Malaysia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 155: Malaysia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 156: Thailand Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 157: Global Vs. Thailand Growth Comparison
Figure 158: Thailand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 159: Thailand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 160: Thailand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 161: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 162: Oceania Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 163: Oceania Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 164: Oceania Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 165: Oceania Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 166: Oceania Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 167: Oceania Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 168: Oceania Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 169: Oceania Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 170: Oceania Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 171: Australia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 172: Global Vs. Australia Growth Comparison
Figure 173: Australia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 174: Australia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 175: Australia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 176: New Zealand Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Growth Comparison
Figure 178: New Zealand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 179: New Zealand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 180: New Zealand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 181: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
Figure 182: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 183: Middle East & Africa Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 184: Middle East & Africa Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 185: Middle East & Africa Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 186: Middle East & Africa Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 187: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
Figure 188: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
Figure 189: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
Figure 190: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
Figure 191: GCC Countries Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Growth Comparison
Figure 193: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 194: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 195: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 196: Turkiye Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 197: Global Vs. Turkiye Growth Comparison
Figure 198: Turkiye Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 199: Turkiye Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 200: Turkiye Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 201: South Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 202: Global Vs. South Africa Growth Comparison
Figure 203: South Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 204: South Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 205: South Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 206: North Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 207: Global Vs North Africa Growth Comparison
Figure 208: North Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 209: North Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 210: North Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Product Code: PMRREP33292

Vaginal Antifungals Market - Report Scope

A recent market study published by Persistence Market Research on the vaginal antifungals market offers a global industry analysis for 2017 to 2021 and an opportunity assessment for 2022 to 2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the vaginal antifungals market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the vaginal antifungals market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the vaginal antifungals market in the most comprehensive way for a better understanding of readers.

Key Market Segments

The study on the vaginal antifungals market offers insights divided into four important segments - drug, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

Fluconazole

Nystatin

Flucytosine

Clotrimazole

Ketoconazole

Terbinafine

Others

Route of Administration

Oral

Topical

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

Chapter 1 - Executive Summary

The report commences with the executive summary of the vaginal antifungals market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the vaginal antifungals market as well as the key trends influencing the market.

Chapter 2 - Market Overview

Readers can find detailed taxonomy and drug definition/scope /limitations and inclusions and exclusions of the vaginal antifungals market in this chapter, which helps the readers to understand basic information about the vaginal antifungals market.

Chapter 3 - Key Market Trends

This section highlights the key trends influencing the vaginal antifungals market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 4 - Key Success Factors

This section highlights the market context impacting the vaginal antifungals market, which will help readers in understanding promotional strategies, by key manufacturers, key regulations, reimbursement scenario, pipeline analysis, value chain analysis, PESTEL analysis, and Porter's analysis, that are expected to create a positive impact on the growth of the vaginal antifungals market during the forecast period.

Chapter 5- Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the vaginal antifungals market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the vaginal antifungals market, which include the drivers, restraints, and opportunity analysis.

Chapter 6 - COVID-19 Crisis Analysis

This section provides the current and expected impact of COVID-19 on the vaginal antifungals market.

Chapter 7- Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

This section explains the global market value or size analysis and forecasts for the vaginal antifungals market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2032).

Chapter 8- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Drug

Based on the drug, the vaginal antifungals market is segmented into Fluconazole, Nystatin, Flucytosine, Clotrimazole, Ketoconazole, Terbinafine, and others. In this chapter, readers can find information about a detailed analysis of the market by different drugs available in the vaginal antifungals market and their growth over the forecast period.

Chapter 9- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

Based on the route of administration, the vaginal antifungals market is segmented into oral, and topical. In this chapter, readers can find information about a detailed analysis of the market by various routes of administration available in the vaginal antifungals market and their growth over the forecast period.

Chapter 10- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

Based on the distribution channel, the vaginal antifungals market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In this chapter, readers can find information about a detailed analysis of the market by distribution channels available in the vaginal antifungals market and their growth over the forecast period.

Chapter 11 - Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Region

This chapter explains how the vaginal antifungals market will grow across seven geographic regions, North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa (MEA).

Chapter 12- North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the North American vaginal antifungals market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on drug, distribution channel, route of administration, and country of the vaginal antifungals market in the North American region.

Chapter 13- Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters based on drug, distribution channel, route of administration, and country in the Latin America vaginal antifungals market during 2022-2032.

Chapter 14- Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and the Rest of Europe are included in this chapter.

Chapter 15- East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia vaginal antifungals market through 2032.

Chapter 16- South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia vaginal antifungals market growth over the forecast period.

Chapter 17- Oceania Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter consists of important parameters that have a huge impact on the growth of the vaginal antifungals market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania vaginal antifungals market.

Chapter 18- Middle East and Africa Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter provides information on how the vaginal antifungals market will grow in the major countries in the MEA region, such as GCC Countries, Turkiye, and the rest of MEA during 2022-2032.

Chapter 19- Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the vaginal antifungals market.

Chapter 20- Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the vaginal antifungals market including company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., and Amplyx Pharmaceuticals Inc.

Chapter 21 - Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 22 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the vaginal antifungals market.

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Key Innovation / Development Trends

4. Key Success Factors

4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Reimbursement Scenario
4.4. Pipeline Analysis
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Antifungal Drugs Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Impact of the COVID-19 Pandemic
- 5.2.2. Increasing Product Launch Activities
- 5.2.3. Prevalence of Vaginal Fungal Infections in HRT Patients
- 5.2.4. High Rates of Vulvovaginal Candidiasis
- 5.2.5. Impact on Quality-of-Life
- 5.2.6. Increasing Number of People with Predisposing Conditions Such as Diabetes Treated with SGLT2 Inhibitors
- 5.2.7. Growing Problems of Azole Resistance
- 5.2.8. Toxicity of Antifungal Drugs
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Drug
- 6.1.2. By Route of Administration
- 6.1.3. By Distribution Channel
- 6.1.4. By Country
6.2. 2021 Market Scenario

7. Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Drug

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2017 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2022 - 2032
- 8.3.1. Fluconazole
- 8.3.2. Nystatin
- 8.3.3. Flucytosine
- 8.3.4. Clotrimazole
- 8.3.5. Ketoconazole
- 8.3.6. Terbinafine
- 8.3.7. Others
8.4. Market Attractiveness Analysis By Drug

9. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2032
- 9.3.1. Oral
- 9.3.2. Topical
9.4. Market Attractiveness Analysis By Route of Administration

10. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2017 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Region

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region

12. North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Drug
- 12.3.3. By Route of Administration
- 12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Drug
- 12.4.3. By Route of Administration
- 12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Vaginal Antifungals Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 12.8.1.2.1. By Drug
    - 12.8.1.2.2. By Route of Administration
    - 12.8.1.2.3. By Distribution Channel
- 12.8.2. Canada Vaginal Antifungals Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 12.8.2.2.1. By Drug
    - 12.8.2.2.2. By Route of Administration
    - 12.8.2.2.3. By Distribution Channel

13. Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
    - 13.3.1.4.1. By Country
    - 13.3.1.4.2. By Drug
    - 13.3.1.4.3. By Route of Administration
    - 13.3.1.4.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Drug
- 13.4.3. By Route of Administration
- 13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Mexico Vaginal Antifungals Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.1.2.1. By Drug
    - 13.8.1.2.2. By Route of Administration
    - 13.8.1.2.3. By Distribution Channel
- 13.8.2. Brazil Vaginal Antifungals Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.2.2.1. By Country
    - 13.8.2.2.2. By Drug
    - 13.8.2.2.3. By Route of Administration
    - 13.8.2.2.4. By Distribution Channel
- 13.8.3. Argentina Vaginal Antifungals Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.3.2.1. By Drug
    - 13.8.3.2.2. By Route of Administration
    - 13.8.3.2.3. By Distribution Channel

14. Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Drug
- 14.3.3. By Route of Administration
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Drug
- 14.4.3. By Route of Administration
- 14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Vaginal Antifungals Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.1.2.1. By Drug
    - 14.8.1.2.2. By Route of Administration
    - 14.8.1.2.3. By Distribution Channel
- 14.8.2. Italy Vaginal Antifungals Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.2.2.1. By Drug
    - 14.8.2.2.2. By Route of Administration
    - 14.8.2.2.3. By Distribution Channel
- 14.8.3. France Vaginal Antifungals Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.3.2.1. By Drug
    - 14.8.3.2.2. By Route of Administration
    - 14.8.3.2.3. By Distribution Channel
- 14.8.4. U.K. Vaginal Antifungals Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.4.2.1. By Drug
    - 14.8.4.2.2. By Route of Administration
    - 14.8.4.2.3. By Distribution Channel
- 14.8.5. Spain Vaginal Antifungals Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.5.2.1. By Drug
    - 14.8.5.2.2. By Route of Administration
    - 14.8.5.2.3. By Distribution Channel
- 14.8.6. BENELUX Vaginal Antifungals Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.6.2.1. By Drug
    - 14.8.6.2.2. By Route of Administration
    - 14.8.6.2.3. By Distribution Channel
- 14.8.7. Russia Vaginal Antifungals Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.7.2.1. By Drug
    - 14.8.7.2.2. By Route of Administration
    - 14.8.7.2.3. By Distribution Channel

15. East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Drug
- 15.3.3. By Route of Administration
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Drug
- 15.4.3. By Route of Administration
- 15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. China Vaginal Antifungals Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.1.2.1. By Drug
    - 15.8.1.2.2. By Route of Administration
    - 15.8.1.2.3. By Distribution Channel
- 15.8.2. Japan Vaginal Antifungals Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.2.2.1. By Drug
    - 15.8.2.2.2. By Route of Administration
    - 15.8.2.2.3. By Distribution Channel
- 15.8.3. South Korea Vaginal Antifungals Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.3.2.1. By Drug
    - 15.8.3.2.2. By Route of Administration
    - 15.8.3.2.3. By Distribution Channel

16. South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Drug
- 16.3.3. By Route of Administration
- 16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Drug
- 16.4.3. By Route of Administration
- 16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Vaginal Antifungals Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.1.2.1. By Drug
    - 16.8.1.2.2. By Route of Administration
    - 16.8.1.2.3. By Distribution Channel
- 16.8.2. Indonesia Vaginal Antifungals Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.2.2.1. By Drug
    - 16.8.2.2.2. By Route of Administration
    - 16.8.2.2.3. By Distribution Channel
- 16.8.3. Malaysia Vaginal Antifungals Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.3.2.1. By Drug
    - 16.8.3.2.2. By Route of Administration
    - 16.8.3.2.3. By Distribution Channel
- 16.8.4. Thailand Vaginal Antifungals Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.4.2.1. By Drug
    - 16.8.4.2.2. By Route of Administration
    - 16.8.4.2.3. By Distribution Channel

17. Oceania Vaginal Antifungals Market 2017-2021 and Forecast 2022-2032

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Drug
- 17.3.3. By Route of Administration
- 17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Drug
- 17.4.3. By Route of Administration
- 17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. Australia Vaginal Antifungals Market Analysis
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast By Market Taxonomy
    - 17.7.1.2.1. By Drug
    - 17.7.1.2.2. By Route of Administration
    - 17.7.1.2.3. By Distribution Channel
- 17.7.2. New Zealand Vaginal Antifungals Market Analysis
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast By Market Taxonomy
    - 17.7.2.2.1. By Drug
    - 17.7.2.2.2. By Route of Administration
    - 17.7.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkiye
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Drug
- 18.3.3. By Route of Administration
- 18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Drug
- 18.4.3. By Route of Administration
- 18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Vaginal Antifungals Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.1.2.1. By Drug
    - 18.8.1.2.2. By Route of Administration
    - 18.8.1.2.3. By Distribution Channel
- 18.8.2. Turkiye Vaginal Antifungals Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.2.2.1. By Drug
    - 18.8.2.2.2. By Route of Administration
    - 18.8.2.2.3. By Distribution Channel
- 18.8.3. South Africa Vaginal Antifungals Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.3.2.1. By Drug
    - 18.8.3.2.2. By Route of Administration
    - 18.8.3.2.3. By Distribution Channel
- 18.8.4. North Africa Vaginal Antifungals Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.4.2.1. By Drug
    - 18.8.4.2.2. By Route of Administration
    - 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. Pfizer Inc.
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Key Financials
  - 20.3.1.5. SWOT Analysis
  - 20.3.1.6. Strategic Overview
- 20.3.2. Bausch Health Companies Inc
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Key Financials
  - 20.3.2.5. SWOT Analysis
  - 20.3.2.6. Strategic Overview
- 20.3.3. ANI Pharmaceuticals, Inc.
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Key Financials
  - 20.3.3.5. SWOT Analysis
  - 20.3.3.6. Strategic Overview
- 20.3.4. Hikma Pharmaceuticals Plc
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Key Financials
  - 20.3.4.5. SWOT Analysis
  - 20.3.4.6. Strategic Overview
- 20.3.5. Lupin Limited
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Key Financials
  - 20.3.5.5. SWOT Analysis
  - 20.3.5.6. Strategic Overview
- 20.3.6. Mycovia Pharmaceuticals, Inc.
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Key Financials
  - 20.3.6.5. SWOT Analysis
  - 20.3.6.6. Strategic Overview
- 20.3.7. Glenmark Pharmaceuticals Limited
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Key Financials
  - 20.3.7.5. SWOT Analysis
  - 20.3.7.6. Strategic Overview
- 20.3.8. Unique Pharmaceuticals
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Key Financials
  - 20.3.8.5. SWOT Analysis
  - 20.3.8.6. Strategic Overview
- 20.3.9. PEPTONIC medical AB
  - 20.3.9.1. Overview
  - 20.3.9.2. Product Portfolio
  - 20.3.9.3. Sales Footprint
  - 20.3.9.4. Key Financials
  - 20.3.9.5. SWOT Analysis
  - 20.3.9.6. Strategic Overview
- 20.3.10. Aurobindo Pharma Limited
  - 20.3.10.1. Overview
  - 20.3.10.2. Product Portfolio
  - 20.3.10.3. Sales Footprint
  - 20.3.10.4. Key Financials
  - 20.3.10.5. SWOT Analysis
  - 20.3.10.6. Strategic Overview
- 20.3.11. Dr. Reddy's Laboratories
  - 20.3.11.1. Overview
  - 20.3.11.2. Product Portfolio
  - 20.3.11.3. Sales Footprint
  - 20.3.11.4. Key Financials
  - 20.3.11.5. SWOT Analysis
  - 20.3.11.6. Strategic Overview
- 20.3.12. SCYNEXIS, Inc.
  - 20.3.12.1. Overview
  - 20.3.12.2. Product Portfolio
  - 20.3.12.3. Sales Footprint
  - 20.3.12.4. Key Financials
  - 20.3.12.5. SWOT Analysis
  - 20.3.12.6. Strategic Overview
- 20.3.13. Basilea Pharmaceutica Ltd.
  - 20.3.13.1. Overview
  - 20.3.13.2. Product Portfolio
  - 20.3.13.3. Sales Footprint
  - 20.3.13.4. Key Financials
  - 20.3.13.5. SWOT Analysis
  - 20.3.13.6. Strategic Overview
- 20.3.14. Astellas Pharma Inc.
  - 20.3.14.1. Overview
  - 20.3.14.2. Product Portfolio
  - 20.3.14.3. Sales Footprint
  - 20.3.14.4. Key Financials
  - 20.3.14.5. SWOT Analysis
  - 20.3.14.6. Strategic Overview
- 20.3.15. Grupo Ferrer Internacional, S.A.
  - 20.3.15.1. Overview
  - 20.3.15.2. Product Portfolio
  - 20.3.15.3. Sales Footprint
  - 20.3.15.4. Key Financials
  - 20.3.15.5. SWOT Analysis
  - 20.3.15.6. Strategic Overview
- 20.3.16. Pacgen Life Science Corporation
  - 20.3.16.1. Overview
  - 20.3.16.2. Product Portfolio
  - 20.3.16.3. Sales Footprint
  - 20.3.16.4. Key Financials
  - 20.3.16.5. SWOT Analysis
  - 20.3.16.6. Strategic Overview
- 20.3.17. NovaDigm Therapeutics, Inc.
  - 20.3.17.1. Overview
  - 20.3.17.2. Product Portfolio
  - 20.3.17.3. Sales Footprint
  - 20.3.17.4. Key Financials
  - 20.3.17.5. SWOT Analysis
  - 20.3.17.6. Strategic Overview
- 20.3.18. Cidara Therapeutics, Inc.
  - 20.3.18.1. Overview
  - 20.3.18.2. Product Portfolio
  - 20.3.18.3. Sales Footprint
  - 20.3.18.4. Key Financials
  - 20.3.18.5. SWOT Analysis
  - 20.3.18.6. Strategic Overview
- 20.3.19. Amplyx Pharmaceuticals Inc.
  - 20.3.19.1. Overview
  - 20.3.19.2. Product Portfolio
  - 20.3.19.3. Sales Footprint
  - 20.3.19.4. Key Financials
  - 20.3.19.5. SWOT Analysis
  - 20.3.19.6. Strategic Overview

膣用抗真菌薬の世界市場：市場シェアの約3分の1はクロトリマゾール系薬剤が占める

Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 主要な成功要因

第5章 市場の背景

第6章 COVID-19危機分析

第7章 世界の膣用抗真菌薬市場の需要分析と予測

第8章 世界の膣用抗真菌薬市場分析と予測：薬剤別

第9章 世界の膣用抗真菌薬市場分析と予測：投与経路別

第10章 世界の膣用抗真菌薬市場分析と予測：流通チャネル別

第11章 世界の膣用抗真菌薬市場分析と予測：地域別

第12章 北米の膣用抗真菌薬市場分析と予測

第13章 ラテンアメリカの膣用抗真菌薬市場分析と予測

第14章 欧州の膣用抗真菌薬市場分析と予測

第15章 東アジアの膣用抗真菌薬市場分析と予測

第16章 南アジアの膣用抗真菌薬市場分析と予測

第17章 オセアニアの膣用抗真菌薬市場分析と予測

第18章 中東・アフリカ（MEA）の膣用抗真菌薬市場分析と予測

第19章 市場構造分析

第20章 競合分析

第21章 前提条件と使用されている頭字語

第22章 調査手法